Antimetabolite incorporation into DNA: Structural and thermodynamic basis for anticancer activity

被引:9
作者
Gmeiner, WH [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA
关键词
anticancer drugs; antipyrimidines; DNA-modifying proteins;
D O I
10.1002/bip.10214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antimetabolites are a class of effective anticancer drugs that structurally resemble naturally occurring biochemicals and interfere in essential biochemical processes. In this review, the recent literature describing investigations of the structural and thermodynamic basis for the anticancer activity of three antipyrimidines [1-beta-D-arabinofuranosyl cytidine (AraC). 2',2'-difluoro deoxycytidine (dFdC), and 5-fluoro-2'-deoxyuridine (FdUrd)] is summarized Our laboratory, and others, have shown that misincorporation of any of these three antipyrimidines into DNA perturbs the structure and decreases the stability of duplex DNA. These data are useful for rationalizing the, effects of antipyrimidine misincorporation on the activities of proteins required for DNA replication and repair such as DNA topoisomerase I and DNA polymerases. The studies completed to date and summarized in this review demonstrate the utility of investigations into the structure-function relationships between antipyrimidine-substituted DNA complexed with DNA-modifying proteins for the purpose of understanding the basis for effective antipyrimidine cancer chemotherapy and the future design of novel anticancer drugs. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:180 / 189
页数:10
相关论文
共 56 条
[1]  
Blackstock AW, 2001, CLIN CANCER RES, V7, P3263
[2]  
Bunn PA, 1998, CLIN CANCER RES, V4, P1087
[3]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[4]   The role of gemcitabine in the treatment of other tumours [J].
Carmichael, J .
BRITISH JOURNAL OF CANCER, 1998, 78 (Suppl 3) :21-25
[5]  
Champoux JJ, 1990, DNA TOPOLOGY ITS BIO, P217
[6]   EFFECTS OF 5-FLUOROURACIL GUANINE WOBBLE BASE-PAIRS IN Z-DNA - MOLECULAR AND CRYSTAL-STRUCTURE OF D(CGCGFG) [J].
COLL, M ;
SAAL, D ;
FREDERICK, CA ;
AYMAMI, J ;
RICH, A ;
WANG, AHJ .
NUCLEIC ACIDS RESEARCH, 1989, 17 (03) :911-923
[7]   Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy Cooperative Oncology Group [J].
Comella, P ;
Frasci, G ;
Panza, N ;
Manzione, L ;
De Cataldis, G ;
Cioffi, R ;
Maiorino, L ;
Micillo, E ;
Lorusso, V ;
Di Rienzo, G ;
Filippelli, G ;
Lamberti, A ;
Natale, M ;
Bilancia, D ;
Nicolella, G ;
Di Nota, A ;
Comella, G .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) :1451-1457
[8]  
DUSENBURY CE, 1991, MOL PHARMACOL, V39, P285
[9]  
Edler D, 2000, CLIN CANCER RES, V6, P1378
[10]   Effects of nucleoside analog incorporation on DNA binding to the DNA binding domain of the GATA-1 erythroid transcription factor [J].
Foti, M ;
Omichinski, JG ;
Stahl, S ;
Maloney, D ;
West, J ;
Schweitzer, BI .
FEBS LETTERS, 1999, 444 (01) :47-53